UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

ý

Rule 13d-1(b)

o

Rule 13d-1(c)

o

Rule 13d-1(d)

CUSIP No.  002824 10 0

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Abbott Laboratories Stock Retirement Trust 36-6047554

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

o

(b)

o

3.

SEC Use Only

4.

Citizenship or Place of Organization
Illinois

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

6.

Shared Voting Power 
61,715,742

7.

Sole Dispositive Power 
0

8.

Shared Dispositive Power
61,715,742

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
61,715,742

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
Not Applicable

11.

Percent of Class Represented by Amount in Row (9)
4.0%

12.

Type of Reporting Person (See Instructions)
EP

CUSIP No.  002824 10 0

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Thomas C. Freyman

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

o

(b)

ý

3.

SEC Use Only

4.

Citizenship or Place of Organization
United States

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
176,820 (Does not include shares held in the Abbott Laboratories Stock Retirement Trust for the benefit of the reporting person)

6.

Shared Voting Power 
65,028,208 - See Attached Exhibit 1

7.

Sole Dispositive Power 
176,820 direct (see note in 5 above)

8.

Shared Dispositive Power
65,028,208 - See Attached Exhibit 1

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
65,649,889 (Total of 5 + 6 + 444,861 shares – right to acquire by exercise of stock options)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
Not Applicable

11.

Percent of Class Represented by Amount in Row (9)
4.2%

12.

Type of Reporting Person (See Instructions)
IN

CUSIP No.  002824 10 0

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Greg W. Linder

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

o

(b)

ý

3.

SEC Use Only

4.

Citizenship or Place of Organization
United States

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
71,943  (Does not include shares held in the Abbott Laboratories Stock Retirement Trust for the benefit of the reporting person)

6.

Shared Voting Power 
65,028,208 - See Attached Exhibit 1

7.

Sole Dispositive Power 
71,943  direct (see note in 5 above)

8.

Shared Dispositive Power
65,028,208 - See Attached Exhibit 1

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
65,342,314  (Total of 5 + 6 + 242,163 shares – right to acquire by exercise of stock options)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
Not Applicable

11.

Percent of Class Represented by Amount in Row (9)
4.2%

12.

Type of Reporting Person (See Instructions)
IN

CUSIP No.  002824 10 0

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Thomas M. Wascoe

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

o

(b)

ý

3.

SEC Use Only

4.

Citizenship or Place of Organization
United States

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
68,902  (Does not include shares held in the Abbott Laboratories Stock Retirement Trust for the benefit of the reporting person)

6.

Shared Voting Power 
65,028,208 - See Attached Exhibit 1

7.

Sole Dispositive Power 
68,902  direct (see note in 5 above)

8.

Shared Dispositive Power
65,028,208 - See Attached Exhibit 1

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
65,535,361 (Total of 5 + 6 + 438,251 shares – right to acquire by exercise of stock options)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
Not Applicable

11.

Percent of Class Represented by Amount in Row (9)
4.2%

12.

Type of Reporting Person (See Instructions)
IN

CUSIP No.  002824 10 0

Item 1.

(a)

Name of Issuer
Abbott Laboratories

(b)

Address of Issuer’s Principal Executive Offices
100 Abbott Park Road
Abbott Park, Illinois 60064-6400

Item 2.

(a)

Name of Person Filing
Abbott Laboratories Stock Retirement Trust

Thomas C. Freyman

Greg W. Linder

Thomas M. Wascoe

(b)

Address of Principal Business Office or, if none, Residence
100 Abbott Park Road

Abbott Park, Illinois  60064-6400

(c)

Citizenship
Abbott Laboratories Stock Retirement Trust – Illinois

Thomas C. Freyman, Greg W. Linder and Thomas M. Wascoe – United States

(d)

Title of Class of Securities
Common Stock, without par value

(e)

CUSIP Number
002824 10 0

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

o

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)

o

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)

o

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)

o

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

(e)

o

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

ý

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

o

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)

o

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

o

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

o

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

CUSIP No.  002824 10 0

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)-(c)     See cover pages 2, 3, 4 and 5, Items 5 through 9 and 11.

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   ý.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable

Item 8.

Identification and Classification of Members of the Group

Not applicable

Item 9.

Notice of Dissolution of Group

Not applicable

Item 10.

Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Abbott Laboratories Stock Retirement Trust

DATED: February 10, 2005

/s/ Thomas C. Freyman

Thomas C. Freyman, Co-Trustee

/s/ Greg W. Linder 

Greg W. Linder, Co-Trustee

/s/ Thomas M. Wascoe 

Thomas M. Wascoe, Co-Trustee